Barrett’s Esophagus (BE)
is associated with long-term GERD and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with BE for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy.